The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Addition of anti-PD1 antibodies to chemotherapy (CT) in first-line treatment of advanced esophageal cancer (EC): A systematic review and meta-analysis.
 
Anastasia Rice
No Relationships to Disclose
 
Mikhail Fedyanin
No Relationships to Disclose
 
Ekaterina Ignatova
No Relationships to Disclose
 
Elizaveta Polyanskaya
No Relationships to Disclose
 
Elmira Dinaeva
No Relationships to Disclose
 
Natalia Besova
No Relationships to Disclose
 
Alexey Tryakin
Stock and Other Ownership Interests - Amgen; Bayer; Lilly; Merck; Merck Serono
Consulting or Advisory Role - Amgen; AstraZeneca; BioCad; Bristol-Myers Squibb; Eisai; Lilly; Merck Sharp & Dohme; Roche/Genentech
Speakers' Bureau - Amgen; Bayer; Bayer Health; BioCad; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; Merck Sharp & Dohme; Pfizer; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BioCad; Merck Serono; Novartis; Sanofi; Veropharm